Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review

Visceral leishmaniasis (VL) is the most lethal of all leishmaniasis diseasesand the second most common parasiticdisease after malaria and,still, categorized as a neglected tropical disease (NTD). According to the latest WHO study, >20 Leishmania species spread 0.7–1.0 million new cases of leishma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Prakash, Kumar, Pawan, Singh, Nidhi, Khajuria, Salil, Patel, Rahul, Rajana, Vinod Kumar, Mandal, Debabrata, Velayutham, Ravichandiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794769/
https://www.ncbi.nlm.nih.gov/pubmed/36588956
http://dx.doi.org/10.3389/fbioe.2022.1016925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794769/
https://www.ncbi.nlm.nih.gov/pubmed/36588956
http://dx.doi.org/10.3389/fbioe.2022.1016925

Ejemplares similares